Trends in Pharmacological Sciences
Trends in Pharmacological Sciences is a journal indexed in SJR in Pharmacology and Toxicology with an H index of 252. It has a COP Index of 13,0 (best band D1). It is published in English. It has a COP Index of 13,0.
Trends in Pharmacological Sciences focuses its scope in these topics and keywords: receptor, gpr, implications, py, cancer, centurynew, family, intake, capecitabine, actions, ...
2 of 115 journals in Toxicology
Metrics
Scimago and CountryOfPapers database fields
COP Index
13,0
D1 Top 10%
SJR Impact
3,771
H-index
252
Docs (year)
115
Docs 3y
304
Total refs
8163
Cites 3y
3758
Citable 3y
289
Cites/Doc 2y
12.38
Ref/Doc
70.98
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Caffeine protects against Parkinson's disease?
View moreWelcome to the first European congress of pharmacology
View moreEndogenous ligands and inverse agonism
View moreDoes a radiolabelled ligand bind to a homogeneous population of non-interacting receptor sites?
View moreDictionary of Cytokines
View moreDevelopment of novel drug delivery systems
View moreDetoxification of a bacterial toxin by the toxin itself
View moreDetection of receptor subtypes in radioligand binding studies Do saturation and homologous competition studies have different discriminatory power?
View moreDelayed protection of the heart against ischaemia
View moreDawson and tricklebank reply
View moreCyclic ADP-ribose, the ryanodine receptor and Ca2+ release
View moreControlling the vasculature: Angiogenesis, anti-angiogenesis and vascular targeting of gene therapy
View moreCCK receptor polymorphisms: an illustration of emerging themes in pharmacogenomics
View moreA magic life of chemistry
View moreButler et al. reply
View moreBiodiversity and new drugs
View moreBeta3-adrenergic agonism: A new concept in human pharmacotherapy
View moreBenefits of ethological analysis of behaviour
View moreApproaches to the development of novel antihypertensive drugs: crucial role of the renal kallikrein-kinin system
View moreAnderson and Coyle reply
View moreAnandamide -the other side of the coin
View moreAn evolutionary view of drug-receptor interaction: the bioamine receptor family
View moreAdenosine, antioxidant enzymes and cytoprotection
View moreA scientific approach to herbal psychopharmacology
View more